The Investor Relations website contains ... Investor Overview. Latest News Releases. View All. 4/10/24 ... Stock Quote. NBIX (Common Stock). $134.37. Change. + ...
... Investor Overview · Stock Information · Financial ... (Nasdaq: NBIX) announced today that it has ... Presentation Link Placeholder (Available May 1, 2024 at 7:00 ...
Dec 14, 2021 · Neurocrine Biosciences, Inc. (Nasdaq: NBIX) financial results for the second quarter ended June 30, 2022 and reiterated financial guidance for ...
People also ask
What is the annual revenue of neurocrine biosciences?
What is NBI 1065845?
Feb 27, 2024 · 27, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at three upcoming investor conferences in March. ( ...
Find the latest institutional holdings data for Neurocrine Biosciences, Inc. Common Stock (NBIX) including shareholders, ownership summaries, ...
Feb 8, 2024 · We believe investing in these areas will continue to drive long term shareholder returns. Now onto our 2024 financial guidance. Story continues.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...